Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

Analysis of Vδ1 T cells in clinical grade melanoma-infiltrating lymphocytes

γδ T cells, including Vδ1 and Vδ2 T cells, can recognize tumor-associated ligands neglected by conventional αβ T cells in a MHC-independent manner. Little is known regarding the anticancer potential and the possibility to isolate and expand Vδ1 T cells to therapeutically relevant numbers. In this s...

Full description

Bibliographic Details
Main Authors:	Donia, Marco, Ellebaek, Eva, Andersen, Mads Hald, Straten, Per thor, Svane, Inge Marie
Format:	Online
Language:	English
Published:	Landes Bioscience 2012
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3518502/

Similar Items

Adoptive cell therapy with tumor infiltrating lymphocytes and intermediate dose IL-2 for metastatic melanoma
by: Andersen, Rikke, et al.
Published: (2014)

Characterization of Ex Vivo Expanded Tumor Infiltrating Lymphocytes from Patients with Malignant Melanoma for Clinical Application
by: Junker, Niels, et al.
Published: (2011)

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients
by: Ellebaek, Eva, et al.
Published: (2012)

T cell therapy in combination with Vemurafenib in BRAF mutated metastatic melanoma patients
by: Borch, Troels Holz, et al.
Published: (2014)

BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer
by: Donia, Marco, et al.
Published: (2012)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
by: Svane, I, et al.
Published: (2014)

Effects of Ipilimumab on expanded tumor infiltrating lymphocytes in patients with stage IV malignant melanoma
by: Bjørn, Jon, et al.
Published: (2013)

Polyfunctional incompletely differentiated CD8+ T cells accumulates after adoptive transfer of tumor-infiltrating lymphocytes and establish immunological memory in patients with metastatic melanoma
by: Donia, Marco, et al.
Published: (2015)

Characterization of Spontaneous Immune Responses against Long Peptides Derived from Bcl-X(L) in Cancer Patients Using Elispot
by: Larsen, Stine Kiaer, et al.
Published: (2012)

The anti-apoptotic members of the Bcl-2 family are attractive tumor-associated antigens
by: thor Straten, Per, et al.
Published: (2010)

A Potential Role of Indoleamine 2,3-Dioxygenase–Specific T cells in Leishmania Vaccination
by: Straten, Per thor, et al.
Published: (2011)

Depletion of T lymphocytes is correlated with response to temozolomide in melanoma patients
by: Iversen, Trine Zeeberg, et al.
Published: (2013)

Natural CD4+ T-Cell Responses against Indoleamine 2,3-Dioxygenase
by: Munir, Shamaila, et al.
Published: (2012)

Broadening the repertoire of melanoma-associated T-cell epitopes
by: Frøsig, Thomas Mørch, et al.
Published: (2015)

Effector CD4 and CD8 T Cells and Their Role in the Tumor Microenvironment
by: Hadrup, Sine, et al.
Published: (2012)

Clonal expansion of renal cell carcinoma-infiltrating T lymphocytes
by: Sittig, Simone P, et al.
Published: (2013)

The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4+ T cells
by: Munir, Shamaila, et al.
Published: (2013)

Association of a functional Indoleamine 2,3-dioxygenase 2 genotype with specific immune responses
by: Køllgaard, Tania, et al.
Published: (2012)

HLA-A24 and survivin: possibilities in therapeutic vaccination against cancer
by: Andersen, Mads Hald, et al.
Published: (2006)

T-cell clonotypes in cancer
by: thor Straten, Per, et al.
Published: (2004)

Pre-Vaccination Frequencies of Th17 Cells Correlate with Vaccine-Induced T-Cell Responses to Survivin-Derived Peptide Epitopes
by: Køllgaard, Tania, et al.
Published: (2015)

Exploitation of gamma delta T cells in cancer immunotherapy as combined antigen-presenters and cancer cell killers
by: Holmen Olofsson, Gitte, et al.
Published: (2014)

Characterization of T-cell responses against IκBα in cancer patients
by: Munir, Shamaila, et al.
Published: (2012)

Combined killing of cancer cells and cross presentation of tumor antigen by Vγ9Vδ2 T cells
by: Olofsson, Gitte Holmen, et al.
Published: (2015)

Long-lasting disease stabilization in the absence of toxicity in metastatic lung cancer patients vaccinated with an HLA-A2-restricted epitope derived from indoleamine 2,3 dioxygenase
by: Iversen, Trine Z, et al.
Published: (2013)

Skewed Differentiation of Circulating Vγ9Vδ2 T Lymphocytes in Melanoma and Impact on Clinical Outcome
by: Toia, Francesca, et al.
Published: (2016)

The antigen specific composition of melanoma tumor infiltrating lymphocytes?
by: Hadrup, Sine Reker
Published: (2012)

Tumor-infiltrating lymphocytes predict cutaneous melanoma survival
by: Fortes, Cristina, et al.
Published: (2015)

Durable Clinical Responses and Long-Term Follow-Up of Stage III–IV Non-Small-Cell Lung Cancer (NSCLC) Patients Treated With IDO Peptide Vaccine in a Phase I Study—A Brief Research Report
by: Julie Westerlin Kjeldsen, et al.
Published: (2018-09-01)

High frequency of T cells specific for cryptic epitopes in melanoma patients
by: Andersen, Rikke Sick, et al.
Published: (2013)

Role of signal transduction and microRNAs on the immunogenicity of melanoma cells
by: Meyer, Stefanie, et al.
Published: (2015)

Tumour-infiltrating lymphocytes in metastatic malignant melanoma and response to interferon alpha treatment.
by: Håkansson, A., et al.
Published: (1996)

Characterization of Human γδ T Lymphocytes Infiltrating Primary Malignant Melanomas
by: Cordova, Adriana, et al.
Published: (2012)

Reprogramming of Melanoma Tumor-Infiltrating Lymphocytes to Induced Pluripotent Stem Cells
by: Saito, Hidehito, et al.
Published: (2016)

Clinical results of combined vemurafenib and tumor-infiltrating lymphocyte therapy for metastatic melanoma
by: Sarnaik, Amod, et al.
Published: (2015)

The specific targeting of immune regulation: T-cell responses against Indoleamine 2,3-dioxygenase
by: Andersen, Mads Hald
Published: (2012)

CD4 responses against IDO
by: Andersen, Mads Hald
Published: (2012)

Keeping each other in check: A reciprocal relationship between cytokines and miRNA
by: Andersen, Mads Hald
Published: (2013)

T-cell dependent immunoselection
by: Andersen, Mads Hald
Published: (2012)

FOXP3-specific immunity
by: Andersen, Mads Hald
Published: (2013)